Gline Matthew sold ROIV
April 16, 2026 · Form 4 insider transaction
Gline Matthew sold 289,774 shares of Roivant Sciences Ltd. at $29.16 per share, a transaction worth $8.45M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
289,774
Price
$29.16
Total value
$8.45M
InsiderGline Matthew
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateApril 16, 2026
Filing dateApril 20, 2026
Shares owned after16,736,116
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.98 to $29.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.